Related Experiment Video
Updated: Nov 6, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Drug Intake and Actinic Keratosis: A Case-Control Study
Andrea Sechi1, Ambra di Altobrando1, Eugenio Cerciello1
1Dermatology, IRCCS Policlinico di Sant'Orsola. Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Italy.
High exposure to angiotensin II receptor blockers (ARBs) and antiplatelet agents may increase the risk of developing actinic keratosis (AK), a premalignant skin condition. This study highlights potential drug-induced factors in AK development.
Area of Science:
- Dermatology
- Oncology
- Pharmacology
Background:
- Actinic keratosis (AK) is a premalignant condition of keratinocyte dysplasia.
- Recent research suggests photosensitizing drugs may play a role in AK development.
Purpose of the Study:
- To evaluate the association between photosensitizing drug use and AK development.
- To identify other medications potentially linked to AK.
Main Methods:
- A case-control study involving 90 AK patients and 90 controls.
- Data collected on cumulative drug exposure, including active ingredient, dosage, and duration.
- Sociodemographic factors and sun exposure habits were also recorded.
Main Results:
- Angiotensin II receptor blockers (ARBs) and antiplatelet agents were identified as independent risk factors for AK.
- High ARB exposure showed a significant association (OR = 13.6).
- Antiplatelet agent use demonstrated a dose-dependent correlation with AK risk.
Conclusions:
- Significant exposure to ARBs and antiplatelet agents may contribute to AK development.
- These medications are potential promoters of AK carcinogenesis in susceptible individuals.
More Related Videos
12:37Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Prevention
Some...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Mutagenicity and Carcinogenicity
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...